Remove 2008 Remove Concentrates Remove Safety Remove Terpenes
article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., Dr. Wakshlag is currently available for interviews to discuss the results of the safety study as well as his clinical trials.

Safety 45
article thumbnail

Doctor Block…….”A Physician Botanist’s Insight to Cannabis species: The Naming of Plants and Products”

TheAnswerPage

In addition to THC and CBD, different cultivars also express various combinations of terpenes, flavinoids, and other minor cannabinoids. Cannabis plants in each of these chemotypes may be further subcategorized based on the content of other cannabinoids and/or terpene profiles. Retrieved 2008-06-20. Chemical Classifications.

Sativa 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What is weed’s new CRC tech, and can it hurt you?

SpeedWeed

Safety data is limited, and testing for CRC contamination is missing—even in legalization states. Marcus Moates, the owner of Nature’s Lab Extracts , has been making extracts in the legal market since 2008. The research and safety data on CRC tech products certainly remains thin. CRC’s main harm is less terpenes.

Hash 52
article thumbnail

What is THC? Here’s everything you need to know

The Cannigma

The safety of using these products however, is still unknown. Here are some factors that can influence your experience: other cannabinoids and terpenes the consumption method you prefer your own unique biological makeup. The first researcher who identified and isolated THC, was the American Roger Adams (Shutterstock).

THC 98
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. 2018 ; Frankhauser 2008 ). At the same time, the outlook on cannabis research data is largely positive.